Price Alert

Corcept Therapeutics (CORT)

NASDAQ: CORT · Real-Time Price · USD

71.72

-0.28 (-0.39%)

At close: Aug 15, 2025, 3:59 PM

71.75

0.03%

After-hours: Aug 15, 2025, 04:54 PM EDT

Corcept Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	194.43M	157.21M	181.89M	182.55M	163.8M	146.81M	135.41M	123.6M	117.72M	105.65M	103.06M	101.73M	103.39M	93.69M	98.82M	96.13M	91.59M	79.44M
Cost of Revenue	3.43M	2.4M	2.96M	2.87M	2.52M	2.54M	1.88M	1.65M	1.57M	1.39M	1.48M	1.34M	1.32M	1.25M	1.35M	1.27M	1.38M	1.27M
Gross Profit	191M	154.81M	178.93M	179.68M	161.27M	144.27M	133.53M	121.96M	116.14M	104.27M	101.58M	100.39M	102.07M	92.44M	97.47M	94.86M	90.2M	78.17M
Operating Income	26.68M	3.42M	25.26M	46.6M	35.59M	29.5M	31.67M	31.18M	29.58M	14.85M	22.5M	31.93M	31.43M	26.77M	36.66M	36.23M	31.94M	19.64M
Interest Income	5.02M	6.2M	6.7M	6.34M	6M	5.49M	5.14M	5.21M	3.35M	3.58M	1.78M	1.07M	630K	80K	72K	72K	110K	275K
Pretax Income	31.69M	9.62M	31.96M	52.94M	41.6M	34.99M	36.81M	36.38M	32.93M	18.43M	24.28M	33M	32.06M	26.85M	36.74M	36.3M	32.05M	19.91M
Net Income	35.15M	20.29M	30.39M	46.69M	35.49M	27.76M	31.36M	31.38M	27.53M	15.88M	16.6M	34.61M	27.41M	22.8M	32.05M	30.47M	26.52M	23.46M
Selling & General & Admin	103.85M	90.66M	83.37M	73.75M	66.94M	56.27M	47.15M	45.26M	43.28M	48.56M	42.32M	35.16M	37.81M	37.55M	32.28M	30.53M	30.03M	29.51M
Research & Development	60.47M	60.73M	70.3M	59.34M	58.74M	58.51M	54.71M	45.52M	43.28M	40.85M	36.75M	33.29M	32.83M	28.12M	28.52M	28.09M	28.23M	29.02M
Other Expenses	n/a	n/a	n/a	n/a	500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	164.32M	151.4M	153.67M	133.08M	125.68M	114.77M	101.86M	90.78M	86.56M	89.42M	79.08M	68.45M	70.64M	65.67M	60.8M	58.62M	58.26M	58.53M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	167.75M	153.8M	156.63M	135.95M	128.2M	117.31M	103.74M	92.42M	88.13M	90.8M	80.56M	69.79M	71.95M	66.92M	62.16M	59.9M	59.65M	59.8M
Income Tax Expense	-3.46M	-10.93M	1.21M	5.73M	6.11M	7.23M	5.45M	5.01M	5.4M	2.56M	7.67M	-1.6M	4.65M	4.05M	4.68M	5.83M	5.53M	-3.55M
Shares Outstanding (Basic)	104.11M	104.11M	103.64M	103.37M	103.12M	102.79M	102.45M	102.01M	101.96M	107.89M	107.7M	115.17M	114.16M	113.98M	113.74M	115.79M	116.29M	116.82M
Shares Outstanding (Diluted)	120.48M	119.82M	118.46M	113.72M	111.24M	109.92M	110.89M	111.1M	109.59M	115.42M	116.33M	116.62M	115.4M	115.04M	122.43M	125.14M	126.68M	129.67M
EPS (Basic)	0.33	0.19	0.29	0.45	0.34	0.27	0.30	0.31	0.27	0.15	0.15	0.30	0.24	0.20	0.28	0.26	0.23	0.20
EPS (Diluted)	0.29	0.17	0.26	0.41	0.32	0.25	0.28	0.28	0.25	0.14	0.14	0.30	0.24	0.20	0.26	0.24	0.21	0.18
EBITDA	27.14M	3.88M	25.72M	47.1M	41.85M	29.62M	32.24M	31.47M	29.89M	15.14M	23.25M	32.69M	32.1M	27.57M	37.46M	37M	32.7M	20.38M
EBIT	26.68M	3.42M	25.26M	46.6M	41.6M	29.5M	31.67M	31.18M	29.58M	14.85M	22.5M	31.93M	31.43M	26.77M	36.66M	36.23M	31.94M	19.64M
Depreciation & Amortization	469K	462K	460K	499K	257K	120K	572K	289K	305K	291K	747K	752K	668K	802K	797K	771K	756K	743K